|
|
|
|
New study links diabetes, depression, and death
A recent study examining the relationship between diabetes, depression, and death demonstrates a need for diabetes patients and pharmacists to be familiar with the symptoms of depression. "We know that people with diabetes who have depression are at a much greater risk of mortality than similar people without diabetes," said Xuanping Zhang, Ph.D., a researcher with the National Center for Chronic Disease Prevention and Health Promotion at the Centers for Disease Control & Prevention in Atlanta.
|
| |
More>>
|
|
|
|
|
|
There are novel agents in the pipeline for diabetes
In the next few years, the treatment of diabetes may change dramatically. If just some of the drugs in phase III trials fulfill their current promise and reach market, we may see the following developments. Pinch yourself. These things are really happening in diabetes therapy—and happening fast.
|
| |
More>>
|
|
|
|
|
|
Make way for a new era of insulin therapy
Insulin therapies have evolved to the point where Drs. Frederick Banting and Charles Best would hardly recognize their own discovery. With the advent of modern recombinant DNA technology, scientists have developed insulin analogs that better mimic the body's normal insulin action. Now, more predictable basal and bolus insulin therapies help achieve tighter glucose control.
|
| |
More>>
|
|
|
|
|
|
Rapid- and slow-acting insulins help control diabetes
If the united states' healthcare trend continues on its current course, in 20 years the number of people with diabetes will more than double to 50 million. This dismaying prediction comes from a new report from the Yale Schools of Public Health and Medicine in conjunction with the Institute for Alternative Futures. If the current trend continues, by 2025.
|
| |
More>>
|
|
|
We subscribe to the HONcode principles of the Health On the Net Foundation